A cancer diagnosis for a beloved family dog is heart-wrenching. Not all lymphomas are the same, however, and prognoses differ for each.
Cardiologists need to know how to recognize and manage the cardiac effects that can arise from SARS-CoV-2 infections or COVID ...
Conclusions: There is a potential mismatch between what clinicians identify as important in determining palliative care need and final eligibility determinations. Patients with dementia were less ...
The addition of steroids to standard care significantly reduces the risk for death in adults with community-acquired ...
Despite having a higher risk of mortality, Medicare beneficiaries who have dementia are less likely to be referred to palliative care than other Medicare beneficiaries, according to a new study ...
Point-of-care ultrasound (POCUS) involves performing US examinations directly at the point of patient care in both prehospital and hospital settings.1,2 POCUS involves using US diagnostics by medical ...
Inspiratory muscle training (IMT) may improve exercise tolerance and cardiorespiratory capacity among adults with post-COVID-19 syndrome.
From lab bench to clinic, discover how a centuries-old superfruit translates into measurable gains in glycemic control, lipid profiles, skin health, and resilience against oxidative stress.
Prior research suggests that SSRIs may reduce the risk of developing long COVID, a condition affecting approximately 65 million individuals worldwide that is associated with fatigue, cognitive ...
A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...
LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...
Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a potent and ...